Director dealings: Redcentric's Alan Aubrey raises stake.

Redcentric revealed on Friday that non-executive director Alan Aubrey had acquired 69,164 ordinary shares in the AIM-listed IT managed services firm.

Source: Sharecast

Aubrey, who joined the board of Redcentric in July 2022, purchased the shares at an average price of 86.75p, for a total value of £59,999.77.

Following the transaction, Aubrey holds a beneficial interest in 106,396 ordinary Redcentric shares.

As of 1530 GMT, Redcentric shares were up 0.92% at 88.31p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Redcentric (RCN)
Director name: Aubrey,Alan John
Amount purchased: 69,164 @ 86.75p
Value: £59,999.77

Kazera Global (KZG)
Director name: Jennings,Richard
Amount purchased: 4,086,800 @ 1.00p
Value: £40,868.00

The Schiehallion Fund Limited Npv (MNTN)
Director name: Colquhoun,Wendy
Amount purchased: 18,137 @ $2.19
Value: $39,720.03

Kazera Global (KZG)
Director name: Dulieu,Paul
Amount purchased: 2,130,000 @ 1.40p
Value: £29,820.00

Top Director Sells

Redcentric ( RCN )

ISIN: GB00BVV5L858

Exchange: London Stock Exchange

Sell:

88.83 p

Buy:

91.41 p

Change: 3.10 ( 3.59 %)

Date:

30/10/2026 - 16:35

Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.